Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

[1]  K. Subbarao,et al.  Live attenuated influenza vaccine. , 2020, Current topics in microbiology and immunology.

[2]  R. Cummings,et al.  Influenza binds phosphorylated glycans from human lung , 2019, Science Advances.

[3]  P. Kulkarni,et al.  Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study , 2018, Drug Safety.

[4]  R. Webby,et al.  A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells , 2017, Journal of Virology.

[5]  M. Tortajada-Girbés,et al.  Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. , 2017, Vaccine.

[6]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season , 2017, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  C. Ambrose,et al.  Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis , 2017, Open forum infectious diseases.

[8]  A. Glatman-Freedman,et al.  A(H1N1)pdm09 influenza infection: vaccine inefficiency , 2017, Oncotarget.

[9]  C. Ambrose,et al.  Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  T. Kepler,et al.  Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain , 2016, Nature Medicine.

[11]  L. Rudenko,et al.  Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories , 2016, Vaccine.

[12]  K. Neuzil,et al.  Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial , 2016, The Lancet. Global health.

[13]  J. Bresee,et al.  Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial , 2016, The Lancet. Global health.

[14]  C. Ambrose,et al.  Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. , 2016, Vaccine.

[15]  L. Grohskopf,et al.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[16]  A. Monto,et al.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. , 2016, The Journal of infectious diseases.

[17]  Xiyan Xu,et al.  Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses , 2015, Journal of virological methods.

[18]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[19]  K. Subbarao,et al.  The Matrix Gene Segment Destabilizes the Acid and Thermal Stability of the Hemagglutinin of Pandemic Live Attenuated Influenza Virus Vaccines , 2014, Journal of Virology.

[20]  R. Albrecht,et al.  Turkey versus guinea pig red blood cells: hemagglutination differences alter hemagglutination inhibition responses against influenza A/H1N1. , 2014, Viral immunology.

[21]  Richard D Cummings,et al.  Cross-platform comparison of glycan microarray formats. , 2014, Glycobiology.

[22]  A. Bavdekar,et al.  Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine , 2014, Human vaccines & immunotherapeutics.

[23]  H. Jin,et al.  A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity , 2014, PLoS pathogens.

[24]  D. Burke,et al.  Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution , 2013, Science.

[25]  O. Engelhardt,et al.  An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. , 2012, Vaccine.

[26]  D. Jarvis,et al.  Letter to the Glyco-Forum: Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities , 2011 .

[27]  C. Davis,et al.  The development of vaccine viruses against pandemic A(H1N1) influenza. , 2011, Vaccine.

[28]  G. Kemble,et al.  Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs , 2009, Journal of Virology.

[29]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[30]  James C Paulson,et al.  Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. , 2006, Journal of molecular biology.

[31]  G. Whittaker,et al.  Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses , 2003, Traffic.

[32]  Yoshihiro Kawaoka,et al.  Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses , 2000, Journal of Virology.

[33]  P S Kim,et al.  Influenza hemagglutinin is spring-loaded by a metastable native conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Aleksandrova Gi.  Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus , 1977 .

[35]  W. Barclay,et al.  Urgent challenges in implementing live attenuated influenza vaccine. , 2018, The Lancet. Infectious diseases.

[36]  Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season. , 2016, Releve epidemiologique hebdomadaire.

[37]  P. Auewarakul,et al.  Effects of the Q223R mutation in the hemagglutinin (HA) of egg-adapted pandemic 2009 (H1N1) influenza A virus on virus growth and binding of HA to human- and avian-type cell receptors. , 2013, Acta virologica.

[38]  G. Kemble,et al.  Genetic engineering of live attenuated influenza viruses. , 2012, Methods in molecular biology.

[39]  A. Klimov,et al.  Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. , 1996, Bulletin of the World Health Organization.

[40]  G. Aleksandrova.  [Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus]. , 1977, Voprosy virusologii.